Engineering Nanoplatforms for Theranostics of Atherosclerotic Plaques DOI

Yuying Liu,

Zeyu Jiang,

Yang Xiao

et al.

Advanced Healthcare Materials, Journal Year: 2024, Volume and Issue: 13(16)

Published: April 2, 2024

Atherosclerotic plaque formation is considered the primary pathological mechanism underlying atherosclerotic cardiovascular diseases, leading to severe events such as stroke, acute coronary syndromes, and even sudden cardiac death. Early detection timely intervention of plaques are challenging due lack typical symptoms in initial stages. Therefore, precise early play a crucial role risk stratification achieving favorable post-interventional outcomes. The continuously advancing nanoplatforms have demonstrated numerous advantages including high signal-to-noise ratio, enhanced bioavailability, specific targeting capabilities for imaging agents therapeutic drugs, enabling effective visualization management plaques. Motivated by these superior properties, various noninvasive modalities recognition preliminary stage atherosclerosis comprehensively summarized. Additionally, several strategies proposed enhance efficacy treating Finally, existing challenges promising prospects accelerating clinical translation nanoplatform-based molecular therapy discussed. In conclusion, this review provides an insightful perspective on diagnosis

Language: Английский

Hyaluronic Acid Receptor‐Mediated Nanomedicines and Targeted Therapy DOI

Qiuhong Ouyang,

Ying Zhao, Kunyao Xu

et al.

Small Methods, Journal Year: 2024, Volume and Issue: unknown

Published: July 23, 2024

Abstract Hyaluronic acid (HA) is a naturally occurring polysaccharide found in the extracellular matrix with broad applications disease treatment. HA possesses good biocompatibility, biodegradability, and ability to interact various cell surface receptors. Its wide range of molecular weights modifiable chemical groups make it an effective drug carrier for delivery. Additionally, overexpression specific receptors on surfaces many states enhances accumulation drugs at pathological sites through receptor binding. In this review, modification drugs, major proteins, latest advances receptor‐targeted nano delivery systems (DDS) treatment tumors inflammatory diseases are summarized. Furthermore, functions varying vivo selection methods different discussed.

Language: Английский

Citations

14

Nano‐bio interactions between 2D nanomaterials and mononuclear phagocyte system cells DOI Creative Commons
Jing Zhao, Zheng Chen,

Shanbiao Liu

et al.

BMEMat, Journal Year: 2024, Volume and Issue: 2(2)

Published: Jan. 10, 2024

Abstract Two‐dimensional (2D) nanomaterials, known for their unique atomic arrangements and exceptional physicochemical properties, have garnered significant attention in biomedical applications, particularly the realms of immunotherapy tissue engineering tumor therapy. These applications necessitate a thorough assessment potential influence 2D nanomaterials on immune cells. Notably, mononuclear phagocyte system (MPS) cells, which play pivotal roles both innate adaptive immunity, are essential maintaining organismal homeostasis. MPS cells with phagocytic capability contribute to prevention foreign body invasion elimination dead or senescent Furthermore, including macrophages dendritic serve as vital bridges between responses. Therefore, understanding nano‐bio interactions is imperative. cellular uptake, cytocompatibility, immunological impact invaluable purposeful design nanomaterials. Herein, we provide an overview latest advancements discuss current challenges future prospects employing field nanomedicine.

Language: Английский

Citations

13

Precise Design of TiO2@CoOx Heterostructure via Atomic Layer Deposition for Synergistic Sono‐Chemodynamic Oncotherapy DOI Creative Commons
Wen Liu,

Runrun Shao,

Lingyun Guo

et al.

Advanced Science, Journal Year: 2024, Volume and Issue: 11(14)

Published: Feb. 4, 2024

Abstract Sonodynamic therapy (SDT), a tumor treatment modality with high tissue penetration and low side effects, is able to selectively kill cells by producing cytotoxic reactive oxygen species (ROS) ultrasound‐triggered sonosensitizers. N‐type inorganic semiconductor TiO 2 has ROS quantum yields under ultrasound irradiation inadequate anti‐tumor activity. Herein, using atomic layer deposition (ALD) create heterojunction between porous CoO x , the sonodynamic efficiency of can be improved. Compared conventional techniques, controllability ALD allows for delicate loading nanoparticles into pores, resulting in precise tuning interfaces energy band structures ultimately optimal SDT properties. In addition, exhibits cascade H O →O →·O − response microenvironment, which not only mitigates hypoxia during process, but also contributes effect chemodynamic (CDT). Correspondingly, synergistic CDT/SDT successful inhibiting growth. Thus, provides new avenues catalytic other pharmaceutical applications.

Language: Английский

Citations

13

Nanomaterials-Involved Tumor-Associated Macrophages’ Reprogramming for Antitumor Therapy DOI
Shulan Li,

Hua‐Ying Hou,

Xu Chu

et al.

ACS Nano, Journal Year: 2024, Volume and Issue: 18(11), P. 7769 - 7795

Published: Feb. 29, 2024

Tumor-associated macrophages (TAMs) play pivotal roles in tumor development. As primary contents of environment (TME), TAMs secrete inflammation-related substances to regulate tumoral occurrence and There are two kinds TAMs: the tumoricidal M1-like protumoral M2-like TAMs. Reprogramming from immunosuppressive M2 immunocompetent M1 phenotype is considered a feasible way improve immunotherapeutic efficiency. Notably, nanomaterials show great potential for biomedical fields due their controllable structures properties. many types that exhibit regulatory activities TAMs' reprogramming. In this review, recent progress nanomaterials-involved reprogramming comprehensively discussed. The various strategies summarized introduced. Additionally, challenges perspectives efficient therapy discussed, aiming provide inspiration regulator design promote development TAMs-mediated immunotherapy.

Language: Английский

Citations

13

Engineering Nanoplatforms for Theranostics of Atherosclerotic Plaques DOI

Yuying Liu,

Zeyu Jiang,

Yang Xiao

et al.

Advanced Healthcare Materials, Journal Year: 2024, Volume and Issue: 13(16)

Published: April 2, 2024

Atherosclerotic plaque formation is considered the primary pathological mechanism underlying atherosclerotic cardiovascular diseases, leading to severe events such as stroke, acute coronary syndromes, and even sudden cardiac death. Early detection timely intervention of plaques are challenging due lack typical symptoms in initial stages. Therefore, precise early play a crucial role risk stratification achieving favorable post-interventional outcomes. The continuously advancing nanoplatforms have demonstrated numerous advantages including high signal-to-noise ratio, enhanced bioavailability, specific targeting capabilities for imaging agents therapeutic drugs, enabling effective visualization management plaques. Motivated by these superior properties, various noninvasive modalities recognition preliminary stage atherosclerosis comprehensively summarized. Additionally, several strategies proposed enhance efficacy treating Finally, existing challenges promising prospects accelerating clinical translation nanoplatform-based molecular therapy discussed. In conclusion, this review provides an insightful perspective on diagnosis

Language: Английский

Citations

13